Tagrisso Global and China Top Players Market

Tagrisso (Osimertinib) - Global and China Top Players Market Share and Ranking 2025

Tagrisso Global and China Top Players Market

Tagrisso (Osimertinib) - Global and China Top Players Market Share and Ranking 2025

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Tagrisso (Osimertinib) Market Size and Forecast 2024 to 2031

• The global Tagrisso (Osimertinib) market was valued at US$ XX Million in 2024
• It is estimated to expand at a CAGR of % from 2024 to 2031
• The global Tagrisso (Osimertinib) market is expected to reach the value of US$ XX Million by the end of 2031

Tagrisso (Osimertinib) Market Overview
Tagrisso, also known by its generic name Osimertinib, is a medication used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking the action of certain proteins involved in the growth and spread of cancer cells. Tagrisso is specifically used for the treatment of NSCLC that has certain mutations in the epidermal growth factor receptor (EGFR) gene.



This report studies and analyses global Tagrisso (Osimertinib) status and future trends, helping the client to determine the Tagrisso (Osimertinib) market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Tagrisso (Osimertinib). It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.

Tagrisso (Osimertinib) Market Key Takeaways

(1) Global Tagrisso (Osimertinib) market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Tagrisso (Osimertinib) sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Tagrisso (Osimertinib) sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Tagrisso (Osimertinib) key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Tagrisso (Osimertinib) key producing regions, capacity, production, and year-over-year growth
(6) Tagrisso (Osimertinib) industry chains, upstream, midstream, and downstream

Tagrisso (Osimertinib) Market: Key Players

The competitive landscape of the Tagrisso (Osimertinib) Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Tagrisso (Osimertinib) Market. Some of the major players operating in the Tagrisso (Osimertinib) Market are:
  • AstraZeneca
  • Incepta Pharmaceuticals Ltd
  • Lonza AG
  • Everest Pharmaceuticals
  • Beacon Pharmaceuticals Limited
  • Drug International Limited


Market IntelliX's study on the Tagrisso (Osimertinib) market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Tagrisso (Osimertinib) Market by Type [Analysis by Value from 2020 to 2031]:
  • 40 mg
  • 80 mg


Tagrisso (Osimertinib) Market by Application [Analysis by Value from 2020 to 2031]:
  • Locally Advanced NSCLC
  • Metastatic NSCLC
  • Other


Tagrisso (Osimertinib) Market by Region [Analysis by Value from 2020 to 2031]:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


Tagrisso (Osimertinib) Market Report Includes:

Chapter 1: To describe Tagrisso (Osimertinib) product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Tagrisso (Osimertinib) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 3: China Tagrisso (Osimertinib) market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 4: Global key producing regions of Tagrisso (Osimertinib) , percent & CAGR, 2020 - 2031

Chapter 5: Tagrisso (Osimertinib) industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Tagrisso (Osimertinib) Definition

1.2 Global Tagrisso (Osimertinib) Market Size and Forecast

1.2.1 By Consumption Value, Global Tagrisso (Osimertinib) Market Size, 2020-2031

1.2.2 By Sales Quantity, Global Tagrisso (Osimertinib) Market Size, 2020-2031

1.2.3 Global Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031

1.3 China Tagrisso (Osimertinib) Market Size and Forecast

1.3.1 By Consumption Value, China Tagrisso (Osimertinib) Market Size, 2020-2031

1.3.2 By Sales Quantity, China Tagrisso (Osimertinib) Market Size, 2020-2031

1.3.3 China Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031

1.4 Share of China Tagrisso (Osimertinib) Market with Respect to the Global Market

1.4.1 By Consumption Value, China Tagrisso (Osimertinib) Market Share in Global, 2020-2031

1.4.2 By Sales Quantity, China Tagrisso (Osimertinib) Market Share in Global, 2020-2031

1.4.3 Tagrisso (Osimertinib) Market Size: China VS Global, 2020-2031

1.5 Tagrisso (Osimertinib) Market Dynamics

1.5.1 Tagrisso (Osimertinib) Market Drivers

1.5.2 Tagrisso (Osimertinib) Market Restraints

1.5.3 Tagrisso (Osimertinib) Industry Trends

1.5.4 Tagrisso (Osimertinib) Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Tagrisso (Osimertinib), Global Market Share by Company, 2020-2025

2.2 By Sales Quantity of Tagrisso (Osimertinib), Global Market Share by Company, 2020-2025

2.3 Tagrisso (Osimertinib) Average Selling Price (ASP) by Company, 2020-2025

2.4 Global Tagrisso (Osimertinib) Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Tagrisso (Osimertinib) Concentration Ratio

2.6 Global Tagrisso (Osimertinib) Mergers & Acquisitions, Expansion Plans

2.7 Global Tagrisso (Osimertinib) Manufacturers Product Type

2.8 Head Office and Tagrisso (Osimertinib) Production Site of Key Manufacturer

2.9 Tagrisso (Osimertinib) Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Tagrisso (Osimertinib), China Market Share by Company, 2020-2025

3.2 By Sales Quantity of Tagrisso (Osimertinib), China Market Share by Company, 2020-2025

3.3 China Tagrisso (Osimertinib) Tagrisso (Osimertinib) Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Tagrisso (Osimertinib) Capacity, Output and Capacity Utilization, 2020-2031

4.2 Global Tagrisso (Osimertinib) Capacity by Region

4.3 Global Tagrisso (Osimertinib) Production & Forecast by Region, 2020 VS 2024 VS 2031

4.4 Global Tagrisso (Osimertinib) Production by Region, 2020-2031

4.5 Global Tagrisso (Osimertinib) Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis

5.1 Tagrisso (Osimertinib) Industry Chain

5.2 Tagrisso (Osimertinib) Upstream Analysis

5.2.1 Tagrisso (Osimertinib) Core Raw Materials

5.2.2 Main Manufacturers of Tagrisso (Osimertinib) Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Tagrisso (Osimertinib) Production Mode

5.6 Tagrisso (Osimertinib) Procurement Model

5.7 Tagrisso (Osimertinib) Industry Sales Model and Sales Channels

5.7.1 Tagrisso (Osimertinib) Sales Model

5.7.2 Tagrisso (Osimertinib) Typical Distributors

6 Sights by Product Type

6.1 Tagrisso (Osimertinib) Classification

6.1.1 40 mg

6.1.2 80 mg

6.2 by Type, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031

6.3 by Type, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031

6.4 by Type, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031

6.5 by Type, Global Tagrisso (Osimertinib) Average Selling Price (ASP), 2020-2031

7 Sights by Application

7.1 Tagrisso (Osimertinib) Segment by Application

7.1.1 Locally Advanced NSCLC

7.1.2 Metastatic NSCLC

7.1.3 Other

7.2 by Application, Global Tagrisso (Osimertinib) Consumption Value & CAGR, 2020 VS 2024 VS 2031

7.3 by Application, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031

7.4 by Application, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031

7.5 by Application, Global Tagrisso (Osimertinib) Price, 2020-2031

8 Sales Sights by Region

8.1 By Region, Global Tagrisso (Osimertinib) Consumption Value, 2020 VS 2024 VS 2031

8.2 By Region, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031

8.3 By Region, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031

8.4 North America

8.4.1 North America Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031

8.4.2 By Country, North America Tagrisso (Osimertinib) Market Size Market Share

8.5 Europe

8.5.1 Europe Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031

8.5.2 By Country, Europe Tagrisso (Osimertinib) Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031

8.6.2 By Country/Region, Asia Pacific Tagrisso (Osimertinib) Market Size Market Share

8.7 South America

8.7.1 South America Tagrisso (Osimertinib) Market Size & Forecasts, 2020-2031

8.7.2 By Country, South America Tagrisso (Osimertinib) Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Tagrisso (Osimertinib) Market Size & CAGR, 2020 VS 2024 VS 2031

9.2 By Country, Global Tagrisso (Osimertinib) Consumption Value, 2020-2031

9.3 By Country, Global Tagrisso (Osimertinib) Sales Quantity, 2020-2031

9.4 United States

9.4.1 United States Tagrisso (Osimertinib) Market Size, 2020-2031

9.4.2 by Type, United States Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.4.3 by Application, United States Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.5 Europe

9.5.1 Europe Tagrisso (Osimertinib) Market Size, 2020-2031

9.5.2 by Type, Europe Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.5.3 by Application, Europe Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.6 China

9.6.1 China Tagrisso (Osimertinib) Market Size, 2020-2031

9.6.2 by Type, China Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.6.3 by Application, China Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.7 Japan

9.7.1 Japan Tagrisso (Osimertinib) Market Size, 2020-2031

9.7.2 by Type, Japan Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.7.3 by Application, Japan Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.8 South Korea

9.8.1 South Korea Tagrisso (Osimertinib) Market Size, 2020-2031

9.8.2 by Type, South Korea Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.8.3 by Application, South Korea Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.9 Southeast Asia

9.9.1 Southeast Asia Tagrisso (Osimertinib) Market Size, 2020-2031

9.9.2 by Type, Southeast Asia Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.9.3 by Application, Southeast Asia Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.10 India

9.10.1 India Tagrisso (Osimertinib) Market Size, 2020-2031

9.10.2 by Type, India Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.10.3 by Application, India Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.11 Middle East & Africa

9.11.1 Middle East & Africa Tagrisso (Osimertinib) Market Size, 2020-2031

9.11.2 by Type, Middle East & Africa Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

9.11.3 by Application, Middle East & Africa Tagrisso (Osimertinib) Sales Quantity Market Share, 2024 VS 2031

10 Manufacturers Profile

10.1 AstraZeneca

10.1.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position

10.1.2 AstraZeneca Tagrisso (Osimertinib) Models, Specifications, and Application

10.1.3 AstraZeneca Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.1.4 AstraZeneca Company Profile and Main Business

10.1.5 AstraZeneca Recent Developments

10.2 Incepta Pharmaceuticals Ltd

10.2.1 Incepta Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position

10.2.2 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Models, Specifications, and Application

10.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.2.4 Incepta Pharmaceuticals Ltd Company Profile and Main Business

10.2.5 Incepta Pharmaceuticals Ltd Recent Developments

10.3 Lonza AG

10.3.1 Lonza AG Company Information, Head Office, Market Area, and Industry Position

10.3.2 Lonza AG Tagrisso (Osimertinib) Models, Specifications, and Application

10.3.3 Lonza AG Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.3.4 Lonza AG Company Profile and Main Business

10.3.5 Lonza AG Recent Developments

10.4 Everest Pharmaceuticals

10.4.1 Everest Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

10.4.2 Everest Pharmaceuticals Tagrisso (Osimertinib) Models, Specifications, and Application

10.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.4.4 Everest Pharmaceuticals Company Profile and Main Business

10.4.5 Everest Pharmaceuticals Recent Developments

10.5 Beacon Pharmaceuticals Limited

10.5.1 Beacon Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position

10.5.2 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Models, Specifications, and Application

10.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.5.4 Beacon Pharmaceuticals Limited Company Profile and Main Business

10.5.5 Beacon Pharmaceuticals Limited Recent Developments

10.6 Drug International Limited

10.6.1 Drug International Limited Company Information, Head Office, Market Area, and Industry Position

10.6.2 Drug International Limited Tagrisso (Osimertinib) Models, Specifications, and Application

10.6.3 Drug International Limited Tagrisso (Osimertinib) Sales Quantity, Revenue, Price and Gross Margin, 2020-2025

10.6.4 Drug International Limited Company Profile and Main Business

10.6.5 Drug International Limited Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Tagrisso (Osimertinib) Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Tagrisso (Osimertinib) Market trending toward high growth trajectories?
A dynamic process in the Tagrisso (Osimertinib) Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like AstraZeneca Incepta Pharmaceuticals Ltd Lonza AG Everest Pharmaceuticals Beacon Pharmaceuticals Limited Drug International Limited.
How competitive is the Tagrisso (Osimertinib) Market going to be?
The strategic moves of the Tagrisso (Osimertinib) Market players such as AstraZeneca Incepta Pharmaceuticals Ltd Lonza AG Everest Pharmaceuticals Beacon Pharmaceuticals Limited Drug International Limited, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What are the major applications for Tagrisso (Osimertinib)?
Tagrisso (Osimertinib) has a wide range of applications, including and others.
What is the market value of the Tagrisso (Osimertinib) Industry?
In 2024, the Tagrisso (Osimertinib) Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What is Tagrisso (Osimertinib) Market Concentration Rate?
In addition to the Tagrisso (Osimertinib) Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the Tagrisso (Osimertinib) Market.
What does the future hold for the Tagrisso (Osimertinib) Industry?
This latest research publication on the Tagrisso (Osimertinib) Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.